CN103599416B - A kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain - Google Patents

A kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain Download PDF

Info

Publication number
CN103599416B
CN103599416B CN201310586845.9A CN201310586845A CN103599416B CN 103599416 B CN103599416 B CN 103599416B CN 201310586845 A CN201310586845 A CN 201310586845A CN 103599416 B CN103599416 B CN 103599416B
Authority
CN
China
Prior art keywords
herba
treatment
muscle strain
lumbar muscle
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310586845.9A
Other languages
Chinese (zh)
Other versions
CN103599416A (en
Inventor
李庆丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Li Qingli
Liu Zundao
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310586845.9A priority Critical patent/CN103599416B/en
Publication of CN103599416A publication Critical patent/CN103599416A/en
Application granted granted Critical
Publication of CN103599416B publication Critical patent/CN103599416B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain, it be galloped along on horseback by Herba Cirrohopetali Andersonii, mountain flower life, Caulis Bambusae Germinatus, Caulis et Folium Lactucae Sativae, black bone, magnificent winged euonymus, Herba malachii aquatici, Herba Heliotroph, Flos Woodfordiae Fruticosae, Herba Tricyrtis Pilosae, Herba Monochoriae Korsakowii, asparagus, Herba indigoferae bungeanae, Herba Lysimachiae Insignis, Radix Cacaliae Ainsliaeflorae make.The drug regimen composition formula for the treatment of chronic lumbar muscle strain of the present invention is reasonable, and composition is simple and easy to get, evident in efficacy, and does not have obvious side effect.

Description

A kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain
Technical field
The present invention relates to nursing in operating room field, specifically, the present invention relates to a kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain.
Background technology
Lumbar muscle strain common cause is that waist excessively bears a heavy burden for a long time or waist posture is bad for a long time, makes waist muscle ligament in tension enduringly.As lower back during peasant's field labour often excessively bear a heavy burden, overtired, the strain of this long term accumulation, causes that muscle, ligament are chronic to be torn, and occur inflammatory reaction, so that lumbago is lasting difficult.After waist acute sprain, the local tissue damaged such as muscle, ligament, controls or wrong treatment if lose, and damage fails to recover, and delay becomes chronic, and repeated multiple times psoas muscle slight damage also can cause chronic lumbar muscle strain.Therefore, be extremely necessary to develop a kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain.
Summary of the invention
The object of this invention is to provide a kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain.
In order to realize object of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain, it is the medicament be made up according to weight proportion of following ingredients:
Raw 3 weight portion Caulis Bambusae Germinatus 15 weight portions of Herba Cirrohopetali Andersonii 5 weight portion mountain flower
The black bone of Caulis et Folium Lactucae Sativae 5 weight portion is galloped along on horseback 3 weight portions China winged euonymus 5 weight portions
Herba malachii aquatici 10 weight portion Herba Heliotroph 5 weight portion Flos Woodfordiae Fruticosae 5 weight portion
Herba Tricyrtis Pilosae 10 weight portion Herba Monochoriae Korsakowii 20 weight portion asparagus 5 weight portion
Herba indigoferae bungeanae 10 weight portion Herba Lysimachiae Insignis 3 weight portion Radix Cacaliae Ainsliaeflorae 5 weight portion.
The pharmaceutical composition for the treatment of chronic lumbar muscle strain of the present invention preferably can be made into tablet (dispersible tablet), capsule, (hard capsule), granule etc.
Chinese crude drug used in the present invention is described as follows according to " Chinese medicine voluminous dictionary ":
The drug regimen composition formula for the treatment of chronic lumbar muscle strain of the present invention is reasonable, and composition is simple and easy to get, evident in efficacy, and does not have obvious side effect.
Detailed description of the invention
The following examples will be further described the present invention, but not thereby limiting the invention.
The granule of embodiment 1 pharmaceutical composition of the present invention
Get Herba Cirrohopetali Andersonii 5 grams, raw 3 grams of mountain flower, Caulis Bambusae Germinatus 15 grams, Caulis et Folium Lactucae Sativae 5 grams, black bone gallop along on horseback 3 grams, magnificent winged euonymus 5 grams, Herba malachii aquatici 10 grams, Herba Heliotroph 5 grams, Flos Woodfordiae Fruticosae 5 grams, Herba Tricyrtis Pilosae 10 grams, Herba Monochoriae Korsakowii 20 grams, asparagus 5 grams, Herba indigoferae bungeanae 10 grams, Herba Lysimachiae Insignis 3 grams, Radix Cacaliae Ainsliaeflorae 5 grams, pulverized 80 mesh sieves, add Icing Sugar 60 grams, mannitol 100 grams of mix homogeneously, with the amidin soft material of 8%, pelletize, evenly assigns in 100 bags.
Test example
Choose 78 routine patients, man 43 example, female 35 example; The oldest 72 years old, minimum 23 years old, average 46.7 years old; The course of disease is the longest 16 years, the shortest 6 months.
Diagnostic criteria: heavy time 1. light during flank pain symptom, severe patient lumbar vertebra deformity, need lean on crutch walking, even be unable to leave the bed; 2. muscular spasm often shows side musculus sacrospinalis, gluteus or both sides; 3. pressure pain point is extensive, the most common with spinous process both sides, transverse process of lumbar vertebra and posterior superior iliac spine; 4. pain is radiated to knee usually with fiber crops, seldom to shank and foot; 5. X-ray film, CT finding how without exception, maybe can have hyperosteogeny or deformity of spine.
Get rid of: serious hypertension, coronary heart disease, tuberculosis of spine, osteoporosis, Long-term Hormone person, vertebral artery sclerosis, deformity, myocardial infarction, cerebral arteriosclerosis, old cervical spinal injury, malignant tumor, anemia of pregnant woman, hyperpyrexia patient.
Therapeutic Method:
Granule is prepared, every day 2 times, oral 1 bag at every turn according to the mode described in embodiment 1.Continuous treatment 15 days.
Criterion of therapeutical effect
Cure: lumbago disappears, and waist activity freely.Take a turn for the better: lumbago obviously alleviates, and waist movable function recovers substantially.Do not heal: symptom is not improved.
Result
Through treatment, find that the lumbago of all patients disappears, waist activity freely, therefore all meets the criterion of therapeutical effect of healing.
Untoward reaction and toxic and side effects monitoring
By detect patient blood pressure, pulse, whether there is Nausea and vomiting, dizzy clinical symptoms judges untoward reaction.Setting human normal systolic pressure is between 90-140mmHg, diastolic pressure is between 60-90mmHg, human normal pulse is 60-100 beat/min, blood pressure, the pulse of patient is measured at treatments period, find that the blood pressure and pulse recorded is all within normal range, the phenomenon not exceeding normal interval occurs, and does not occur Nausea and vomiting, dizzy clinical symptoms.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that this medicine does not have obvious toxic and side effects for human body.

Claims (1)

1. treat a pharmaceutical composition for chronic lumbar muscle strain, it is characterized in that, it is the medicament be made up according to weight proportion of following ingredients:
CN201310586845.9A 2013-11-19 2013-11-19 A kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain Expired - Fee Related CN103599416B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310586845.9A CN103599416B (en) 2013-11-19 2013-11-19 A kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310586845.9A CN103599416B (en) 2013-11-19 2013-11-19 A kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain

Publications (2)

Publication Number Publication Date
CN103599416A CN103599416A (en) 2014-02-26
CN103599416B true CN103599416B (en) 2015-09-23

Family

ID=50117722

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310586845.9A Expired - Fee Related CN103599416B (en) 2013-11-19 2013-11-19 A kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain

Country Status (1)

Country Link
CN (1) CN103599416B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1569053A (en) * 2003-07-21 2005-01-26 天津达仁堂制药二厂 Chinese medicinal herb composition for treating rheumatism
CN100998706A (en) * 2006-12-28 2007-07-18 陆宏成 Medical herbs of decoction for treating lumbar muscle degeneration and its preparing method
CN101028472A (en) * 2007-04-05 2007-09-05 胡翠玉 Oral Chinese medicinal composition for treating lumbocostal overstrain

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1569053A (en) * 2003-07-21 2005-01-26 天津达仁堂制药二厂 Chinese medicinal herb composition for treating rheumatism
CN100998706A (en) * 2006-12-28 2007-07-18 陆宏成 Medical herbs of decoction for treating lumbar muscle degeneration and its preparing method
CN101028472A (en) * 2007-04-05 2007-09-05 胡翠玉 Oral Chinese medicinal composition for treating lumbocostal overstrain

Also Published As

Publication number Publication date
CN103599416A (en) 2014-02-26

Similar Documents

Publication Publication Date Title
Brownlee et al. Controlled inversion therapy: an adjunct to the elimination of gravity-dependent fragments following extracorporeal shock wave lithotripsy
Hsu et al. Scoliosis in Duchenne muscular dystrophy (DMD)
CN100546616C (en) A kind of Chinese medicine for the treatment of osteopathia
CN102872238A (en) Medicine for treating osteoarthrosis and preparation method thereof
Walton et al. Benign congenital myopathy with myasthenic features
RU2703881C1 (en) Method for early functional treatment of stable pelvic fractures
CN101732691B (en) Externally applied medicament for preventing and/or treating spondylodynia, osteoarthrosis and gout
CN103599416B (en) A kind of pharmaceutical composition for the treatment of chronic lumbar muscle strain
CN101342290B (en) Tong bi liquid and preparation method thereof
CN102274293A (en) Muscle and bone relaxing capsules
Cummins Metrazol complications as affected by the use of curare
CN102125641B (en) Externally applied medicament for treating lumbar intervertebral disc protrusion
CN105395772A (en) Traditional Chinese medicine composition for treating fractures and pains in neck, shoulder, low back and leg
CN101703649B (en) Chinese patent medicament for treating bone traumatism and preparation process thereof
CN105168315A (en) Zijin blood-dissipating pill for treating soft tissue contusion and early fracture
EP3075380B1 (en) Benzbromarone for use in the treatment of spinal diseases
CN106309992A (en) Traditional Chinese medicine composition for treating osteoproliferation
Lockie et al. Arthritis in the aged
CN105288325A (en) Traditional Chinese medicine for treating arrhythmia caused by deficiency of both vital energy and yin
CN111481653A (en) Medicinal composition for treating hyperosteogeny, preparation method and application thereof
JP3927249B2 (en) Painkiller
CN103784742A (en) Medicinal preparation for treating chronic lumbar strain
Zhou et al. Clinical observation on acupuncture at Jiaji (EX-B 2) points plus tuina in treating thoracic facet joint disorder
Tatham et al. Examination: Endocrine
CN102908605B (en) Orthopedic combination for external use and preparation method and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Li Qingli

Inventor after: Liu Zundao

Inventor before: Li Qingli

CB03 Change of inventor or designer information
TR01 Transfer of patent right

Effective date of registration: 20170816

Address after: The 272000 Ring Road in Shandong province Jining City District No. 3 Jining city hospital operation room

Co-patentee after: Liu Zundao

Patentee after: Li Qingli

Address before: 272100 operation room, Jining City Hospital of traditional Chinese medicine, No. 3 Ring Road, Shizhong District, Shandong, Jining

Patentee before: Li Qingli

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150923

Termination date: 20171119

CF01 Termination of patent right due to non-payment of annual fee